豚インフルエンザ(Swine Influenza)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Swine Influenza 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Swine Influenza to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Swine Influenza to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Swine Influenza 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Swine Influenza Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Sanofi 37
Clinical Trial Overview of Sanofi 37
Serum Institute of India Limited 38
Clinical Trial Overview of Serum Institute of India Limited 38
Cadila Pharmaceuticals Ltd. 39
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 39
Vaxart, Inc. 40
Clinical Trial Overview of Vaxart, Inc. 40
Microgen Scientific Industrial Company for Immunobiological Medicines 41
Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
Chiltern International Ltd. 43
Clinical Trial Overview of Chiltern International Ltd. 43
Bharat Biotech International Limited 44
Clinical Trial Overview of Bharat Biotech International Limited 44
Clinical Trial Overview of Top Institutes / Government 45
The National Institute of Allergy and Infectious Diseases 45
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 45
University of British Columbia 46
Clinical Trial Overview of University of British Columbia 46
Institut National de la Sante et de la Recherche Medicale 47
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 47
University of Rochester 48
Clinical Trial Overview of University of Rochester 48
University Health Network 49
Clinical Trial Overview of University Health Network 49
National Heart, Lung, and Blood Institute 50
Clinical Trial Overview of National Heart, Lung, and Blood Institute 50
The University of Hong Kong 51
Clinical Trial Overview of The University of Hong Kong 51
Hadassah Medical Organization 52
Clinical Trial Overview of Hadassah Medical Organization 52
University Hospitals of Leicester NHS Trust 53
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 53
Five Key Clinical Profiles 54
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 106